Article

A more physiological approach to lipid metabolism alterations in cancer: CRC-like organoids assessment

2018-11-05

Abstract excerpt

Precision medicine might be the response to the recent questioning of the use of metformin as an anticancer drug in colorectal cancer (CRC). Thus, in order to establish properly its benefits, its application need to be assayed on the different progression stages of CRC. In this way, organoids imply a more physiological tool, representing a new therapeutic opportunity for CRC personalized treatment to assay tumor s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b8c89207-d5bf-5036-a4ee-6a5e84dd4147
DOI: 10.1101/462929

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A more physiological approach to lipid metabolism alterations in cancer: CRC-like organoids assessmentDOI 10.1101/462929Read

Colon Cancer and Perturbations of the Sphingolipid MetabolismSemantic proximity Read

Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer.Semantic proximity Read

ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patientsSemantic proximity Read

Epithelial-to-mesenchymal transition lowers the cholesterol pathway, which influences colon tumors differentiationSemantic proximity Read

Cholesterol in colorectal cancer: an essential but tumorigenic precursor?Semantic proximity Read

Microbiota-Derived Short-Chain Fatty Acids: New Road in Colorectal Cancer TherapySemantic proximity Read

ORMDL1 is Upregulated and Associated With Favorable Outcome in Colorectal CancerSemantic proximity Read

Altered lipid metabolism in APC-driven colorectal cancer: the potential for therapeutic interventionSemantic proximity Read

Lipid profiling of mouse intestinal organoids for studying APC mutations.Semantic proximity Read

Screening of patient-derived organoids identifies mitophagy as a cell-intrinsic vulnerability in colorectal cancer during statin treatmentSemantic proximity Read

Phospholipid profiling enables to discriminate tumor- and non-tumor-derived human colon epithelial cells: Phospholipidome similarities and differences in colon cancer cell lines and in patient-derived cell samplesSemantic proximity Read

Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer preventionSemantic proximity Read